Structure | Chemical Name | CAS | MF |
|
5-BROMO-2-FLUORO-4-(TRIFLUOROMETHYL)BENZOIC ACID
|
1699741-92-8
|
C8H3BrF4O2
|
|
:2-Morpholinecarboxamide,4-(8-cyano-5-quinolinyl)-N-((3S,4R) -4- fluoro-3-pyrrolidinyl)-6-methyl-, hydrochloride (1:1), (2R,6R)-
|
1700608-88-3
|
C20H23ClFN5O2
|
|
(2S,6R)-tert-butyl 2-ethyl-6-methylmorpholine-4-carboxylate
|
1700609-48-8
|
C11H21NO4
|
|
1-Piperidinecarboxylic acid, 3-amino-4-fluoro-, 1,1-dimethylethyl ester, (3R,4S)-
|
1700611-18-2
|
C10H19FN2O2
|
|
(3R,4S)-1-(3-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one
|
1700622-06-5
|
C24H21F2NO3
|
|
(3R,4S)-1-(4-fluorophenyl)-3-((S)-3-hydroxy-3-(p-tolyl)propyl)-4-(4-hydroxyphenyl)azetidin-2-one
|
1700622-07-6
|
C25H24FNO3
|
|
(3R,4S)-1-(4-chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one
|
1700622-08-7
|
C24H21ClFNO3
|
|
(R)-(3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl) phenyl)-2-oxooxazolidin-5-yl)methyl butyrate
|
1700656-54-7
|
C21H21FN6O4
|
|
3-Bromo-4-methyl-1-phenyl-1H-pyrazole
|
1700661-39-7
|
C10H9BrN2
|
|
EPZ020411
|
1700663-41-7
|
C25H38N4O3
|
|
JH-II-127
|
1700693-08-8
|
C19H21ClN6O3
|
|
(R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride
|
1701403-10-2
|
C22H23ClN6O
|
|
1-[(4S)-4,5-Dihydro-4-isopropyl-2-oxazolyl]isoquinoline
|
1701405-00-6
|
C15H16N2O
|
|
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)pyrimidine
|
1701434-52-7
|
C11H14BF3N2O2
|
|
2-Benzyloxy-4-(trifluoromethyl)phenylboronic acid
|
1701435-39-3
|
C14H12BF3O3
|
|
4-BROMO-3-HYDROXYPHENYLBORONIC ACID
|
1701448-16-9
|
C6H6BBrO3
|
|
2-(3,4-Dichloro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
1701449-89-9
|
C13H17BCl2O3
|
|
Ezetimibe Impurity 38
|
1701462-59-0
|
C45H58F2N2O5Si2
|
|
[3-(Dimethylamino)-5-fluorophenyl]methanol
|
1701527-56-1
|
C9H12FNO
|
|
1-(Tetrahydro-2H-pyran-4-yl)-1H-imidazol-2-amine
|
1702028-84-9
|
C8H13N3O
|
|
4-Bromo-3-chloro-2-fluorobenzyl alcohol
|
1702154-18-4
|
C7H5BrClFO
|
|
H3B-6527
|
1702259-66-2
|
C29H34Cl2N8O4
|
|
tert-butyl (4-(4-ethylpiperazin-1-yl)-2-nitrophenyl)carbamate
|
1702260-51-2
|
C17H26N4O4
|
|
4-(4-ethylpiperazin-1-yl)-2-nitroaniline
|
1702260-52-3
|
C12H18N4O2
|
|
1-(6-chloropyrimidin-4-yl)-3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methyl-3-((2-(trimethylsilyl)ethoxy)methyl)urea
|
1702260-56-7
|
C20H27Cl3N4O4Si
|
|
Riociguat Impurtiy 6
|
1702271-98-4
|
C18H17FN8
|
|
N-((3R,4R)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
|
1702274-61-0
|
C20H25N5
|
|
tert-butyl 4-(3-chloropropyl)-4-cyanopiperidine-1-carboxylate
|
1702300-72-8
|
C14H23ClN2O2
|
|
Methanesulfonato{(R)-(-)-1-[(S)-2-(dicyclohexylphosphino)ferrocenyl]ethyldi-t-butylphosphine}(2'-amino-1,1'-biphenyl-2-yl)palladium(II)
|
1702311-34-9
|
C45H66FeNO3P2PdS10*-
|
|
Exo-bcn-PEG4-NHS ester
|
1702356-19-1
|
C26H38N2O10
|
|
THZ-531
|
1702809-17-3
|
C30H32ClN7O2
|
|
PI3Kδ-IN-2
|
1702816-75-8
|
C28H37FN6O5S
|
|
Dabigatran Etexilate iMpurity H
|
1702936-92-2
|
C19H20N4O3
|
|
Fosnetupitant
|
1703748-89-3
|
C31H35F6N4O5P
|
|
BLU-285
|
1703793-34-3
|
C26H27FN10
|
|
(4-fluorophenyl)(2-(piperazin-1-yl)pyrimidin-5-yl)methanone
|
1703794-75-5
|
C15H15FN4O
|
|
(4-fluorophenyl)(2-(piperazin-1-yl)pyrimidin-5-yl)methanone hydrochloride
|
1703795-52-1
|
C15H16ClFN4O
|
|
5,10-dibromo-2,2-dimethyl-[1,3]dioxolo[4,5-f][1,10]phenanthroline
|
1703797-07-2
|
C15H12Br2N2O2
|
|
3-broMo-1H-pyrazole-4-carbonitrile
|
1703808-52-9
|
C4H2BrN3
|
|
3-bromo-1-methyl-1H-pyrazole-4-carbonitrile
|
1703808-62-1
|
C5H4BrN3
|
|
METHYL(2S)-2-AMINO-2-[3-FLUORO-4-(TRIFLUOROMETHOXY)PHENYL]ACETATE
|
1703935-54-9
|
C10H9F4NO3
|
|
(2-(4-Methylpiperidin-1-yl)pyridin-3-yl)boronic acid
|
1704063-44-4
|
C11H17BN2O2
|
|
(2-(4-methylpiperidin-1-yl)pyridin-4-yl)boronic acid
|
1704063-45-5
|
C11H17BN2O2
|
|
(3-chloro-2-(4-Methylpiperidin-1-yl)pyridin-4-yl)boronic acid
|
1704063-47-7
|
C11H16BClN2O2
|
|
4-((4-oxopiperidin-1-yl)Methyl)phenylboronic acid
|
1704063-48-8
|
C12H16BNO3
|
|
4-((4-(2-hydroxyethyl)piperazin-1-yl)Methyl)phenylboronic acid
|
1704063-49-9
|
C13H21BN2O3
|
|
4-(3-(4-ethylpiperazin-1-yl)propoxy)phenylboronic acid
|
1704063-50-2
|
C15H25BN2O3
|
|
(3-(2-(4-hydroxypiperidin-1-yl)ethoxy)phenyl)boronic acid
|
1704063-52-4
|
C13H20BNO4
|
|
(3-(2-(4-(tert-butoxycarbonyl)piperazin-1-yl)ethoxy)phenyl)boronic acid
|
1704063-53-5
|
C17H27BN2O5
|
|
(3-(3-(4-Methylpiperidin-1-yl)propoxy)phenyl)boronic acid
|
1704063-54-6
|
C15H24BNO3
|
|
(3-(3-(4-Methylpiperazin-1-yl)propoxy)phenyl)boronic acid
|
1704063-55-7
|
C14H23BN2O3
|
|
(3-(3-(4-(tert-butoxycarbonyl)piperazin-1-yl)propoxy)phenyl)boronic acid
|
1704063-56-8
|
C18H29BN2O5
|
|
(3-(3-(4-ethylpiperazin-1-yl)propoxy)phenyl)boronic acid
|
1704063-57-9
|
C15H25BN2O3
|
|
(3-((4-hydroxypiperidin-1-yl)sulfonyl)phenyl)boronic acid
|
1704063-58-0
|
C11H16BNO5S
|
|
(3-((4-Methylpiperazin-1-yl)sulfonyl)phenyl)boronic acid
|
1704063-59-1
|
C11H17BN2O4S
|
|
(3-(piperazin-1-ylsulfonyl)phenyl)boronic acid
|
1704063-60-4
|
C10H15BN2O4S
|
|
(3-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)boronic acid
|
1704063-61-5
|
C12H19BN2O4S
|
|
2-(4-Methylpiperazin-1-ylsulfonyl)phenylboronic acid
|
1704063-62-6
|
C11H17BN2O4S
|
|
2-(4-(tert-butoxycarbonyl)piperazin-1-ylsulfonyl)phenylboronic acid
|
1704063-63-7
|
C15H23BN2O6S
|
|
2-(4-ethylpiperazin-1-ylsulfonyl)phenylboronic acid
|
1704063-64-8
|
C12H19BN2O4S
|
|
(3-fluoro-5-((4-oxopiperidin-1-yl)Methyl)phenyl)boronic acid
|
1704063-68-2
|
C12H15BFNO3
|
|
(3-(((tert-butoxycarbonyl)(cyclopropyl)aMino)Methyl)-5-fluorophenyl)boronic acid
|
1704063-72-8
|
C15H21BFNO4
|
|
(3-fluoro-5-(MethoxyMethyl)phenyl)boronic acid
|
1704063-73-9
|
C8H10BFO3
|
|
(3-(ethoxyMethyl)-5-fluorophenyl)boronic acid
|
1704063-74-0
|
C9H12BFO3
|
|
(3-fluoro-5-(isopropoxyMethyl)phenyl)boronic acid
|
1704063-75-1
|
C10H14BFO3
|
|
2-(pyrrolidin-1-yl)-5-(trifluoroMethyl)phenylboronic acid
|
1704063-76-2
|
C11H13BF3NO2
|
|
2-(4-Methylpiperidin-1-yl)-5-(trifluoroMethyl)phenylboronic acid
|
1704063-77-3
|
C13H17BF3NO2
|
|
2-(4-ethylpiperazin-1-yl)-5-(trifluoroMethyl)phenylboronic acid
|
1704063-78-4
|
C13H18BF3N2O2
|
|
2-Morpholino-5-(trifluoroMethyl)phenylboronic acid
|
1704063-79-5
|
C11H13BF3NO3
|
|
2-(diMethylaMino)-5-(trifluoroMethyl)phenylboronic acid
|
1704063-80-8
|
C9H11BF3NO2
|
|
4-fluoro-2-(pyrrolidin-1-ylMethyl)phenylboronic acid
|
1704063-81-9
|
C11H15BFNO2
|
|
4-fluoro-2-((4-Methylpiperidin-1-yl)Methyl)phenylboronic acid
|
1704063-82-0
|
C13H19BFNO2
|
|
4-fluoro-2-((4-Methylpiperazin-1-yl)Methyl)phenylboronic acid
|
1704063-83-1
|
C12H18BFN2O2
|
|
2-((4-(tert-butoxycarbonyl)piperazin-1-yl)Methyl)-4-fluorophenylboronic acid
|
1704063-84-2
|
C16H24BFN2O4
|
|
4-fluoro-2-(MorpholinoMethyl)phenylboronic acid
|
1704063-85-3
|
C11H15BFNO3
|
|
2-((diethylaMino)Methyl)-4-fluorophenylboronic acid
|
1704063-86-4
|
C11H17BFNO2
|
|
2-(ethoxyMethyl)-4-fluorophenylboronic acid
|
1704063-87-5
|
C9H12BFO3
|
|
4-fluoro-2-((2,2,2-trifluoroethoxy)Methyl)phenylboronic acid
|
1704063-88-6
|
C9H9BF4O3
|
|
4-fluoro-3-(pyrrolidin-1-ylMethyl)phenylboronic acid
|
1704063-89-7
|
C11H15BFNO2
|
|
4-fluoro-3-((4-hydroxypiperidin-1-yl)Methyl)phenylboronic acid
|
1704063-91-1
|
C12H17BFNO3
|
|
4-fluoro-3-((4-Methylpiperazin-1-yl)Methyl)phenylboronic acid
|
1704063-92-2
|
C12H18BFN2O2
|
|
3-((4-(tert-butoxycarbonyl)piperazin-1-yl)Methyl)-4-fluorophenylboronic acid
|
1704063-93-3
|
C16H24BFN2O4
|
|
3-((4-ethylpiperazin-1-yl)Methyl)-4-fluorophenylboronic acid
|
1704063-94-4
|
C13H20BFN2O2
|
|
4-fluoro-3-(morpholinomethyl)phenylboronic acid
|
1704063-95-5
|
C11H15BFNO3
|
|
3-((diMethylaMino)Methyl)-4-fluorophenylboronic acid
|
1704063-96-6
|
C9H13BFNO2
|
|
4-fluoro-3-((2-Methoxyethoxy)Methyl)phenylboronic acid
|
1704063-97-7
|
C10H14BFO4
|
|
4-fluoro-3-(isopropoxyMethyl)phenylboronic acid
|
1704063-98-8
|
C10H14BFO3
|
|
3-fluoro-4-((4-hydroxypiperidin-1-yl)Methyl)phenylboronic acid
|
1704063-99-9
|
C12H17BFNO3
|
|
4-((4-(tert-butoxycarbonyl)piperazin-1-yl)Methyl)-3-fluorophenylboronic acid
|
1704064-00-5
|
C16H24BFN2O4
|
|
4-((tert-butoxycarbonyl(cyclopropyl)aMino)Methyl)-3-fluorophenylboronic acid
|
1704064-03-8
|
C15H21BFNO4
|
|
4-(3-(4-(tert-butoxycarbonyl)piperazin-1-yl)propoxy)-3-fluorophenylboronic acid
|
1704064-07-2
|
C18H28BFN2O5
|
|
3-fluoro-4-(2-(pyrrolidin-1-yl)ethoxy)phenylboronic acid
|
1704064-09-4
|
C12H17BFNO3
|
|
3-fluoro-4-(2-(4-oxopiperidin-1-yl)ethoxy)phenylboronic acid
|
1704064-10-7
|
C13H17BFNO4
|
|
3-fluoro-4-(2-(4-hydroxypiperidin-1-yl)ethoxy)phenylboronic acid
|
1704064-11-8
|
C13H19BFNO4
|
|
3-fluoro-4-(2-(4-Methylpiperazin-1-yl)ethoxy)phenylboronic acid
|
1704064-12-9
|
C13H20BFN2O3
|
|
4-(2-(4-ethylpiperazin-1-yl)ethoxy)-3-fluorophenylboronic acid
|
1704064-13-0
|
C14H22BFN2O3
|
|
4-(2-(4-(tert-butoxycarbonyl)piperazin-1-yl)ethoxy)-3-fluorophenylboronic acid
|
1704064-14-1
|
C17H26BFN2O5
|
|
3-fluoro-4-(2-Morpholinoethoxy)phenylboronic acid
|
1704064-15-2
|
C12H17BFNO4
|
|
4-(2-(diethylaMino)ethoxy)-3-fluorophenylboronic acid
|
1704064-16-3
|
C12H19BFNO3
|
|
4-(2-(tert-butoxycarbonyl(cyclopropyl)aMino)ethoxy)-3-fluorophenylboronic acid
|
1704064-17-4
|
C16H23BFNO5
|